Craniocaudal tumour extension in uterine cervical cancer on MRI compared to histopathology  by de Boer, Peter et al.
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Purpose:  To assess  the  reliability  of magnetic  resonance  imaging  (MRI)  for evaluation  of craniocaudal
tumour  extension  by comparing  the craniocaudal  tumour  extension  on the  pre-operative  MRI  and  post-
operative  hysterectomy  specimen  in patients  with  early  stage  uterine  cervical  cancer.
Materials  and  methods:  After approval  of  the  institutional  review  board  was  acquired,  pre-operative  MRI
and hysterectomy  specimen  of  21 women  with  early  stage  cervical  cancer  were  re-evaluated.  The cran-
iocaudal  extension  on  MRI was  measured  separately  by two  experienced  radiologists  and  compared
with  corresponding  measurements  from  the  hysterectomy  specimen,  which  were  re-evaluated  by  an
experienced  pathologist.
Results: Median  craniocaudal  extension  of  uterine  cervical  cancer  on  MRI  was  slightly  smaller  compared
to  histopathology  (2.1  cm  vs. 2.5  cm).  The  median  underestimation  was  0.4  cm  (range  −0.6  cm to  2.2 cm,xtension mean  0.4  cm,  standard  deviation  (SD)  ±0.7  cm);  Pearson’s  correlation  was  0.83  (p  < 0.001).  In  two  patients
(9%)  MRI  underestimated  tumour  craniocaudal  extension  by  more  than  1.8  cm.
Conclusion:  MRI  represents  the  histopathological  craniocaudal  tumour  extension  in  the  majority  of
patients  with  early  stage  uterine  cervical  cancer,  but  with  a  systematic  small  underestimation  of  the
real  craniocaudal  tumour  extension.
ublis© 2015  The  Authors.  P
. IntroductionIn patients with uterine cervical cancer, early recognition of
nvolvement into and beyond the uterine internal os is pivotal
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for treatment decision-making in both surgical gynaecology and
radiation therapy (RT). For instance, assessment of craniocaudal
extension is crucial to assess the feasibility and safety of fertility-
sparing surgery, in young women  with early-stage uterine cervical
cancer [1,2]. Possible extension of cervical cancer into the uterine
body is a well-known uncertainty in cancer staging and treatment
of locally advanced uterine cervical cancer treated with (chemo)
radiation [International Federation of Gynaecology and Obstetrics
(FIGO) stage IIB–IVA] [3,4]. Most RT guidelines for cervical cancer
recommend inclusion of the whole uterus in the clinical target vol-
ume  (CTV); this is mainly because, in the past, craniocaudal uterine
invasion could not be excluded by physical examination or com-
puted tomography [4,5].
However, inclusion of the whole uterine corpus into the CTV,
plus a large uncertainty margin for position uncertainty, usu-
ally results in large planning target volumes (PTV) for external
beam RT (EBRT). Large radiation volumes are responsible for the
substantial risk of late complications, such as radiation enteritis,
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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pig. 1. (A) Craniocaudal tumour extension of the primary tumour measured paral
umour extension in a 51-year-old woman with FIGO stage IB1 uterine cervical ca
ranial  and caudal extension.
roctitis and cystitis, as well as ﬁstulae and sexual dysfunction,
ll of which are important constraining factors for dose escala-
ion [6–8]. Therefore, it remains debatable whether the whole
terine body should be included in the CTV, both in EBRT and
n brachytherapy, as recommended in international guidelines
9–12]. Although in 2010, 16 representatives from the National
ancer Institute of Canada (NCIC), the Japan Clinical Oncology
roup (JCOG), and the European Society of Therapeutic Radiol-
gy and Oncology (ESTRO) agreed that the complete uterus should
e included in the CTV, 42% of the expert respondents felt that it
as not always necessary [5]. With the ever-increasing precision of
T techniques, such as volumetric modulated arc therapy (VMAT)
nd magnetic resonance imaging (MRI)-guided brachytherapy, rec-
nciliation of expert recommendations urgently requires more
eliable imaging to determine tumour involvement in surrounding
issues.
Assessment of the craniocaudal tumour extension is required, in
articular, for safe reduction of the radiation volume in inoperable
atients, for which MRI  could be used in radiation practice as it
ncreased the visual identiﬁcation of pelvic tumours and tumour
xtension [13–17]. However, very few studies have investigated
he reliability of tumour extension assessed on MRI  compared to
istopathology [18].
Histopathological veriﬁcation of MRI  tumour extension is of
ourse only possible in patients who can be operated. Therefore, the
resent ‘radiotherapy’ study assesses the reliability of MRI  for eval-he endocervical channel in sagittal plane. (B) Example of measuring craniocaudal
 sagittal plane on MRI  and on pathology (C). The two-headed arrow indicates the
uation of uterine tumour extension by comparing the craniocaudal
tumour extension on the pre-operative MRI  and post-operative
hysterectomy specimen, in patients with early stage uterine cer-
vical cancer who  had surgery alone.
2. Materials and methods
2.1. Study design
This study retrospectively compared craniocaudal extension on
the pre-operative MRI  with (histo) pathology of the surgical spec-
imen in patients who  had a radical hysterectomy for early stage
cervical cancer. Before collecting data, approval of the institutional
review board was  acquired; the board decided that informed con-
sent was  not obligatory.
2.2. Patients
For all women  who had a radical hysterectomy for early stage
cervical cancer between May  2012 and February 2013, the MRI
and histopathological records were analysed. None of the patients
underwent neoadjuvant chemotherapy or radiation therapy. The
present study is complementary to a technical paper wherein we
used the MRIs and surgical specimens of nine of the present patients
to illustrate a mathematical model for deformable registration [19].
There is no double publication of measurements and outcome
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eporting. MRI  techniques had to be comparable: i.e. patients were
xcluded when MRI  was performed elsewhere with different MR
equences, or if imaging quality was appraised by experienced radi-
logists to be insufﬁcient (discussed in detail below). Furthermore,
atients were excluded if there was no residual tumour, e.g. after
rior large loop excision of the transformation zone (LLETZ) on
ither MRI  or histopathological examination of the surgical speci-
en. Related characteristics were registered: age, FIGO stage, time
etween MRI  and histopathology, histopathological type, tumour
ocation in relation to the uterine cervix, and previous surgery of
he uterine cervix.
.3. Histopathology
According to our hospital protocol, the pathologist made a stan-
ard ventral median incision to expose the intrauterine cavity.
hen, a photograph was taken of the plane of incision with a ruler
laced beside. A craniocaudal tumour extension was  measured on
he plane of incision in craniocaudal direction. The recorded cranio-
audal diameter was primarily derived from the macroscopy report
nd veriﬁed by the photograph of the specimen and, if the cervix
as embedded completely, from the microscopy report (Fig. 1c).
valuation was  performed by a pathologist specialized in gynaeco-
ogical tumours and with 5 years related experience.
.4. MRI  procedure
All MRIs acquired between May  2012 and February 2013 were
art of standard preoperative staging and were performed accord-
ng to a standard protocol on a 1.5 Tesla unit (Siemens Avanto,
rlangen, Germany) using a phased array coil. Sequences con-
isted of sagittal, axial oblique and coronal oblique fast T2-weighted
urbo spin-echo (repetition time/echo time 2500/70 ms), ﬁeld of
iew 300 × 300 mm,  acquisition matrix 512 × 384 and a 4 mm slice
hickness. The standard protocol also included an axial diffusion-
eighted sequence. Coronal and axial T2-weighted scans were
ngulated orthogonal and perpendicular to the endocervical canaldiology Open 2 (2015) 111–117 113
to reduce partial volume effects. No bowel relaxants (such as
butylscopolamine) were routinely administered.
2.5. Evaluation of MRI
Before evaluation, a case record form (CRF) was developed
including instructions on how to perform the measurements, based
on consensus between the two  radiologists and the investigator,
with speciﬁc attention paid to how craniocaudal measurements
were spatially made in histopathology (Fig. 1a). To avoid bias from
a learning curve, the CRFs were tested, and adjusted, in 5 patients;
these patients were not included in this study. The T2-weighted
images were evaluated independently by two  radiologists with 19
and 17 years of experience, respectively, in assessing MRI of the
pelvic region. The craniocaudal extension on MRI  was measured
for each patient on the T2 turbo spin-echo sagittal MRI; diffusion
weighted images could be used for tumour assessment. The great-
est craniocaudal extension parallel to the cervical/uterine internal
canal was measured on the MRI  and the mean measurement
between both radiologists was  calculated. MRI  measurements were
performed on the sagittal sequence corresponding to the sagit-
tal plane in which the specimen is evaluated on histopathology.
The radiologists had knowledge of the patient’s medical history
up until the time MRI  was  performed and were blinded to the
histopathology ﬁndings (Fig. 1b). Image quality (good, acceptable,
unacceptable) was registered. If the image quality was scored as
‘acceptable’ or ‘unacceptable’, the suboptimal condition was spec-
iﬁed (i.e. due to angulation, movement artefacts, etc.). In addition,
the position of the tumour in relation to the cervix (central, dorsal,
ventral, left, right) was determined.
2.6. Correlation between radiologists
The intraclass correlation coefﬁcient (ICC) of craniocaudal
tumour extension measurements between the observers was cal-
culated. The ICC is interpreted in the following way: 0 = poor
agreement; 0–0.20 = minor agreement; 0.21–0.40 fair agreement;
0.41–0.60 moderate agreement; 0.61–0.80 major agreement; and
0.81–1.00 almost perfect agreement [20].
2.7. Comparison between MRI and (histo) pathology
The craniocaudal MRI  measurement of tumour extension was
compared to the histopathology measurement of craniocau-
dal tumour extension. The difference in measured craniocaudal
extension between histopathology and MRI  was  presented in a
Bland–Altman plot to show the agreement between the two modal-
ities. If this difference was  ≥1.0 cm a radiation oncologist and
the pathologist discussed possible causes separately. Descriptive
statistics were performed and Pearson’s correlation was  calculated
of the measured craniocaudal extension in MRI and histopathology.
To detect possible correlations between the difference in mea-
sured craniocaudal extension and baseline characteristics (age,
time between MRI  and histopathology, histopathological type,
tumour location in relation to the uterine cervix, and previous
surgery of the uterine cervix), univariate analysis of variance was
calculated. Data were analysed using IBM SPSS Statistics version
21.0.0.1 for Windows.
3. Results3.1. Patients
Between May  2012 and February 2013, 28 patients with early
stage uterine cervical cancer underwent radical hysterectomy. Of
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Fig. 3. (A) Due to diffuse vaso-invasion, the craniocaudal extension of uterine cervical c
macroscopic images.
Table 1
Related baseline characteristics.
Related baseline characteristics
Parameter No. of patients (n = 21)
Age in years: median
(range)
50 (30–68)
FIGO stage:
IA 1 (5)
IB1 17 (81)
IB2 2 (9)
IIA 1 (5)
Pre-treatment:
Biopsy only 10 (48)
LLETZ 5 (24)
Conisation 6 (28)
Tumour location in relation to the uterine cervix on MRI:
Central 10 (48)
Ventral 4 (20)
Dorsal 2 (9)
Left 2 (9)
Right 1 (5)
No visible tumour 2 (9)
Time between MRI  and
hysterectomy: median
days (range)
28 (14–44)
Histopathological type:
Squamous cell carcinoma 16 (76)
Adenocarcinoma 5 (24)
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hote: Unless otherwise indicated, numbers in parentheses are percentages.
IGO—International Federation of Gynaecology and Obstetrics, LLETZ—Large Loop
xcision of the Transformation Zone, MRI—Magnetic Resonance Imaging.
hese, six were excluded because no residual tumour was identi-
ed on MRI  and corresponding histopathology after irradical LLETZ
r conisation. One patient with MRI  from another hospital was
xcluded because of substantial differences compared with our MRI
equences. Finally, 21 patient records were available for further
nalysis (Fig. 2).
.2. Related baseline characteristics
Table 1 summarizes the baseline characteristics. The median age
as 50 (range 30–68, standard deviation (SD) 9.5) years; 17 (81%) ofhe patients had FIGO stage IB1 and four (19%) patients had another
umour stage. Three patients (14%) had a conisation before MRI
nd three patients (14%) had a LLETZ before MRI. One patient (5%)
ad abdominal radical trachelectomy instead of a radical hysterec-ancer (arrows) could not be properly measured in sagittal plane on MRI  (B) or on
tomy. The location of the tumour in relation to the uterine cervix
was assessed on MRI: in 11 patients (52%) tumours were centrally
located, and in two  patients (10%) no (residual) tumour could be
recognised on MRI. In the remaining 8 patients (38%) tumours were
located more to one side of the cervix. The median time between
MRI  and surgery was 28 (range 14–44, SD 8) days. In 16 patients
(76%) a squamous cell carcinoma was  found and the remaining ﬁve
patients (24%) had adenocarcinoma. For the 21 included patients,
the two radiologists assessed the quality of MRI  as ‘good’ in 12 and
14 patients, respectively, and acceptable in 9 and 7 patients, respec-
tively; the slightly lower quality was attributed to the presence of
movement artefacts or suboptimal sequence angulation.
3.3. Histopathology
For all 21 patients, the craniocaudal extension could be
extracted from the pathology reports. In 14 of these patients
the craniocaudal extension could be reassessed based on pho-
tographs of the specimens. In six patients the photographs were
taken after formalin ﬁxation, and in eight patients the photographs
showed fresh specimens. In two patients, the craniocaudal exten-
sions needed to be reassessed by microscopic revision of the slices
due to uncertainties in the pathology report. The median cranio-
caudal extension of the tumour was  2.5 (range 0.5–4.4, SD 1.2)
cm.
3.4. MRI
For both radiologists, on MRI  the median craniocaudal extension
of the tumour was 2.1 cm (range 0–3.5 cm and 0–4.9 cm respec-
tively; SD 1.2 cm and 1.4 cm,  respectively). The combined data from
the two radiologists resulted in the following averages per mea-
surement: range 0–4.2 (median 2.1, SD 1.3) cm.
3.5. Correlation between radiologists
The mean difference in craniocaudal tumour extension between
the radiologists was  0.1 (range −1.4 to 1.5, SD 0.6) cm. The ICC
between the two  radiologists was 0.94 with a 95% conﬁdence inter-
val (CI) of 0.85–0.98. In four cases there was a disagreement of
≥1.0 cm.  In two  of these latter patients, because MRI  was  per-
formed after conisation or LLETZ, the tumour extension and surgical
scar could not be well distinguished, leading to differences in
measurement of the craniocaudal tumour extension between the
radiologists. In one patient, the ﬁrst radiologist found a tumour in
P. de Boer et al. / European Journal of Radiology Open 2 (2015) 111–117 115
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aig. 4. Bland–Altman plot for craniocaudal extension measured on MRI  and histopat
RI  has a systematic error of −0.4 cm or, in other words, MRI  slightly underestimate
eems to get smaller with larger tumours. There were two outlying cases (see Secti
he anterior side of the cervix only, but the second radiologist found
hat the endocervical canal also contained a tumour. Both radiol-
gists found the MRI  quality to be adequate but, in hindsight, the
nterobserver difference of 1.2 cm could be attributed to a subopti-
al  sequence angulation, a situation which also occurs in common
ractice. In the latter case, tumour extension into the uterus was
een on the MRI, but the boundaries could hardly be discriminated
n either MRI  or macroscopy; microscopically the tumour was a
iffusely growing vaso-invasive squamous cell carcinoma inﬁltrat-
ng the whole uterus (Fig. 3). In two patients no (residual) tumour
ould be recognized on MRI  by either of the radiologists.
.6. Comparison of MRI  and histopathology
Fig. 4 shows the differences between histopathology vs. MRI  in
 Bland–Altman plot; the differences were smaller in the larger
umours. MRI  gives a median underestimation of histopathological
xtension of 0.2 (mean 0.4, range −0.6 to 2.2, mean SD 0.7) cm;
earson’s correlation 0.83 (p < 0.001).
In three patients the craniocaudal tumour extension was under-
stimated on MRI  by ≥1 cm (Figs. 4 and 5). In one patient the tumour
ignal intensity on T2-weighted and diffusion-weighted images
esembled endocervical tissue; this tumour extension was not rec-
gnized by either of the radiologists and was recorded as 0.0 cm.
owever, on (histo) pathological examination there was  an evi-
ent macroscopic tumour with a craniocaudal extension of 2.2 cm.
urther examination by a radiation oncologist, and the pathologist
nvolved in the other two cases, showed that the spatial shape of
he tumour differed substantially between MRI  and histopathol-
gy. This was probably caused by post-operative change in tumour
hape of the surgical specimen (Fig. 6). This may  also play a role
n the smaller differences in craniocaudal extensions between MRI
nd histopathology.. The dotted lines show a 95% conﬁdence interval (−1.0 to1.9 cm). It can be seen that
opathology by (on average) 0.4 cm.  The difference between MRI  and histopathology
Univariate analysis of variance of the differences between MRI
and histopathology showed no signiﬁcant inﬂuence of patients’
baseline clinical characteristics (age, time between MRI  and
histopathology, histopathological type, tumour location in relation
to the uterine cervix and previous surgery of the uterine cervix).
4. Discussion
The reliability of MRI  for craniocaudal extension of cervical can-
cer was assessed by comparing the pre-operative MRI with the
surgical specimen in patients who  had undergone hysterectomy
for early stage cervical cancer. The study shows that MRI  slightly
underestimated the mean craniocaudal extension of uterine cervi-
cal cancer extension compared with histopathology. Craniocaudal
tumour extension is particularly important for determining the fea-
sibility of organ-sparing surgery of early cervical cancer, and for
potential sparing of the uterine corpus in RT.
Earlier retrospective analyses showed the presence/absence of
uterine internal os involvement on MRI  with a promising speci-
ﬁcity (93–98%) and sensitivity (86–100%) [21–23]. Furthermore, a
maximal underestimation of 15 mm was reported when measuring
maximal tumour diameter of uterine cervical cancer on MRI  com-
pared to histopathology [24]. However, these latter studies were
designed to determine the largest tumour dimension irrespective
of the orientation and not speciﬁcally to measure craniocaudal
tumour extension. Secondly, although histopathology is usually
considered the gold standard, it is questionable whether (and to
what extent) changes in the shape of the surgical specimen after
hysterectomy and during processing may  have affected maximum
tumour diameter. However, we  aimed to limit these uncertainties
by systematically measuring craniocaudal tumour extension par-
allel to the uterine internal canal in the same spatial plane on both
MRI  and histopathology.
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A limitation of the present study is the small number of patients
and its retrospective design. A more fundamental question is
F
e
aig. 5. Estimation of craniocaudal tumour extension by MRI  compared to (histo) pat
gy  by 2.2 cm.
The current RT treatment planning guidelines for uterine cervi-
al cancer recommend irradiation of the whole uterus but with the
dvent of high-precision RT techniques, such as VMAT and image-
uided RT, it is debatable whether uninvolved parts of the uterine
orpus can be safely excluded to reduce toxicity to the bladder and
ntestines [3,5,25,26]. In addition, radiobiological rules support the
reatment of microscopic disease using lower doses than for macro-
copic disease; ultimately, however, the efﬁcacy of that idea can
nly be proven based on clinical trials [27]. Sanuki et al. found that
f cervical tumours were ≤2 cm,  then no cases of uterine invasion
xceeded ≥1/3 of the uterine body; the authors suggested that,
f these patients had received RT, it would not have been neces-
ary to irradiate the uterine fundus with brachytherapy [25]. Based
n a similar rationale, more normal intestine and bladder would
e spared by excluding the uterine fundus during external beam
ig. 6. Images from a 45-year old woman with FIGO stage IB uterine cervical cancer. On
ndocervical channel is 1.9 cm (A). Despite measurements in exactly the same sagittal p
ltered at pathology and a craniocaudal tumour extension of 4.0 cm is measured (B). Note as reference standard. For instance, in patient 21, MRI  underestimates histopathol-
elective pelvic RT, and by including the fundus ‘electively’ during
brachytherapy.
In the present study, in 19 patients (91%) craniocaudal exten-
sion would have been covered by a clinical uncertainty margin of
1.2 cm (including a mean underestimation of MRI  of 0.4 cm)  and all
patients with a margin of 2.2 cm, despite spatial uncertainties. In
one patient, tumour extension could not be recognized; in this case
the tumour was  highly symmetrical and the MRI  signal resembled
endocervical cavity tissue. To our knowledge no similar cases have
been reported and this might be very rare in a cervical tumour with
a diameter of 2.2 cm.whether the results from surgical patients with early stage cervical
cancer can be safely extrapolated to RT patients with inoperable
 MRI  the craniocaudal tumour extension measured in sagittal plane parallel to the
lane both on MRI  and pathology, the spatial shape of the tumour is substantially
 that on both images the tumour is very well distinguishable from normal tissue.
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[P. de Boer et al. / European Journa
dvanced stage tumours. However, as it is impossible to make a
irect comparison of MRI  and histopathology in large tumours, at
he moment this is the best we can do. Also, this study empha-
izes that, on pathology, the shape of the uterus in vivo can differ
rom that ex vivo; this limitation is inherent to all studies on this
opic. This problem could partially be solved by deformable image
egistration and digital correction of deformations between MRI
nd histopathology [28,29]. Moreover, these uncertainties can be
urther reduced by embedding of the whole hysterectomy speci-
en  and 3D reconstruction of multiple cross-sections [29]. In the
resent study, in those cases where craniocaudal tumour exten-
ion differed ≥1.0 cm between MRI  and histopathology, we show
lear examples of perfectly distinguishable tumours on MRI  and
istopathology which differ in measured size due to in vivo/ex
ivo deformations (Fig. 6). Therefore, ex vivo post-surgical tissue
eformation plays an important role in all these measurements.
. Conclusions
In the present study, MRI  represents the histopathological cran-
ocaudal tumour extension in the majority of patients with cervical
ancer, but with a systematic small underestimation. The next step
s to perform prospective validation of MRI  while ruling out more
patial uncertainties.
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